Vivoryon Therapeutics Announces Successful Private Placement of up to EUR 30 Million

Vivoryon Therapeutics N.V. to Report H1 2022 Financial Results and Operational Progress on September 30, 2022
Vivoryon Therapeutics N.V. Reports H1 2022 Financial Results and Highlights Operational Progress